Skip to content
Qulipta, Aquipta(atogepant)
Aquipta, Qulipta (atogepant) is a small molecule pharmaceutical. Atogepant was first approved as Aquipta on . It is used to treat migraine disorders in the USA. It has been approved in Europe to treat migraine disorders.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
Trade Name
FDA
EMA
Qulipta
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Atogepant
Tradename
Company
Number
Date
Products
QULIPTAAbbVieN-215206 RX2021-09-28
3 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
quliptaNew Drug Application2021-10-12
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
migraine disordersEFO_0003821D008881G43
Agency Specific
FDA
EMA
Expiration
Code
ATOGEPANT, QULIPTA, ABBVIE
2026-09-28NCE
2026-04-17I-909
Patent Expiration
Patent
Expires
Flag
FDA Information
Atogepant, Qulipta, Abbvie
101178362035-01-30DP
98502462033-03-13DP
87540962032-07-19DS, DPU-3534
94995452031-11-10DS, DPU-3534
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02C: Antimigraine preparations
— N02CD: Calcitonin gene-related peptide (cgrp) antagonists
— N02CD07: Atogepant
HCPCS
No data
Clinical
Clinical Trials
17 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Migraine disordersD008881EFO_0003821G4311101—12
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameATOGEPANT
INNatogepant
Description
Atogepant, sold under the brand name QULIPTA, is a medication used to prevent migraines. It is a gepant, an orally active calcitonin gene-related peptide receptor (CGRPR) antagonist.
Classification
Small molecule
Drug classcalcitonin gene-related peptide receptor antagonists
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C[C@@H]1[C@H](c2c(F)ccc(F)c2F)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F
Identifiers
PDB—
CAS-ID1374248-81-3
RxCUI—
ChEMBL IDCHEMBL3991065
ChEBI ID—
PubChem CID72163100
DrugBankDB16098
UNII ID7CRV8RR151 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Qulipta - AbbVie
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 140 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2 adverse events reported
View more details